We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

48 hedge funds and large institutions have $33.5M invested in SQZ Biotechnologies Company in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9% less funds holding

Funds holding: 53 → 48 (-5)

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

29% less capital invested

Capital invested by funds: $47.1M → $33.5M (-$13.7M)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
48
Holders Change
-5
Holders Change %
-9.43%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
11
Reduced
13
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$262K
2
RC
RBF Capital
California
+$150K
3
Stifel Financial
Stifel Financial
Missouri
+$75.5K
4
BCM
Bridgeway Capital Management
Texas
+$75K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$42.3K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$385K
2
Millennium Management
Millennium Management
New York
-$293K
3
Citadel Advisors
Citadel Advisors
Florida
-$139K
4
Morgan Stanley
Morgan Stanley
New York
-$71.8K
5
Goldman Sachs
Goldman Sachs
New York
-$66.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
$6.29M – – –
AIG
2
American International Group
New York
$5.74M – – –
6CM
3
683 Capital Management
New York
$5.12M +$262K +87,262 +4%
AG
4
Artal Group
Luxembourg
$3.66M – – –
N
5
NanoDimension
California
$3.29M – – –
MC
6
Maverick Capital
Texas
$2.44M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.15M – – –
Stifel Financial
8
Stifel Financial
Missouri
$1.12M +$75.5K +25,174 +5%
LCM
9
Laurion Capital Management
New York
$984K – – –
BlackRock
10
BlackRock
New York
$635K -$25.3K -8,433 -3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$309K +$42.3K +14,108 +12%
RC
12
RBF Capital
California
$296K +$150K +50,000 +63%
E
13
Ergoteles
New York
$226K -$16.1K -5,364 -5%
BCM
14
Bridgeway Capital Management
Texas
$150K +$75K +25,000 +61%
Renaissance Technologies
15
Renaissance Technologies
New York
$134K +$2.1K +700 +1%
State Street
16
State Street
Massachusetts
$128K – – –
SCA
17
Sandy Cove Advisors
Massachusetts
$118K – – –
Northern Trust
18
Northern Trust
Illinois
$71K – – –
Goldman Sachs
19
Goldman Sachs
New York
$58K -$66.7K -22,231 -46%
Bank of America
20
Bank of America
North Carolina
$51K +$96 +32 +0.1%
DWM
21
Dakota Wealth Management
Florida
$46K – – –
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$43K +$8.9K +2,966 +19%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$40K -$6.67K -2,223 -11%
Citadel Advisors
24
Citadel Advisors
Florida
$38K -$139K -46,350 -73%
ACM
25
ACT Capital Management
Pennsylvania
$36K – – –
1
2 3

SQZ Hedge Fund Activity: Q3 2022 in Review

48 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q3 2022, worth a combined $33.5M — down 29% from $47.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SQZ and 4 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 11 added.

The largest buyer was 683 Capital Management, adding an estimated $262K. The largest seller was JP Morgan Chase, cutting an estimated $385K.

  • 48 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q3 2022, down from 53 in Q2 2022.
  • Funds reported $33.5M of SQZ Biotechnologies Company stock for Q3 2022, down 29% quarter-over-quarter.
  • 4 funds opened new SQZ Biotechnologies Company positions in Q3 2022 and 9 closed out, a net change of -5 holders.
  • The largest SQZ Biotechnologies Company buyer in Q3 2022 was 683 Capital Management, an estimated $262K added.
  • The largest SQZ Biotechnologies Company seller in Q3 2022 was JP Morgan Chase, an estimated $385K sold.

Based on aggregated 13F filings for Q3 2022.